[HTML][HTML] Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment

H Wu, H Yao, C He, Y Jia, Z Zhu, S Xu, D Li… - … Pharmaceutica Sinica B, 2022 - Elsevier
… representative cases of molecular glues and analyzes the binding mode of the molecular
glue–protein complex. Based on the aggregation mode of molecular glues mediating protein–…

Molecular glues: capable protein-binding small molecules that can change protein–protein interactions and interactomes for the potential treatment of human cancer …

F Li, IAM Aljahdali, X Ling - International Journal of Molecular Sciences, 2022 - mdpi.com
… target could be bound/glued by multiple MG compounds with … generate various molecular
gluing tools for disease mechanism … for the treatment of various types of human diseases, …

Molecular glues: the adhesive connecting targeted protein degradation to the clinic

JM Sasso, R Tenchov, DS Wang, LS Johnson… - Biochemistry, 2022 - ACS Publications
… We also outline the advantages of the molecular glues and summarize the advances in …
progression of molecular glues in drug discovery pipelines and their targeted diseases. Overall, …

Molecular glue degraders: exciting opportunities for novel drug discovery

T Lemaitre, M Cornu, F Schwalen, M Since… - Expert Opinion on …, 2024 - Taylor & Francis
… The concept of protein degradation is concerned with molecular glues, which form part of
the broader field of Targeted Protein Degradation (TPD). Next, pharmacochemical strategies …

PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs

M Maneiro, E De Vita, D Conole, CS Kounde… - Progress in medicinal …, 2021 - Elsevier
… small molecule drugs have been successfully used as treatments for decades, tackling a
variety of disease-… small-molecule inhibitors. To pursue this strategy, heterobifunctional small …

[HTML][HTML] Molecular glues to stabilise protein–protein interactions

L Soini, S Leysen, J Davis, C Ottmann - Current opinion in chemical biology, 2022 - Elsevier
… to our armamentarium to treat diseases like cancer and neurodegeneration. However,
despite this impressive progress, the de-novo development of a molecular glue is a tremendous …

Targeted protein degradation and regulation with molecular glue: past and recent discoveries

Y Fang, Q He, J Cao - Current Medicinal Chemistry, 2022 - ingentaconnect.com
… used in the clinic and are a class of molecular glue that induces degradation of several neo-…
of molecular glues and share our opinions on the identification of novel molecular glues in …

Molecular glue discovery: current and future approaches

JA Dewey, C Delalande, SA Azizi, V Lu… - Journal of medicinal …, 2023 - ACS Publications
… activity can target disease. However, while non-native degradation is the current research
focus, type III molecular glues have also been shown to alleviate disease phenotypes by …

Inhibitors, protacs and molecular glues as diverse therapeutic modalities to target cyclin-dependent kinase

S Rana, JR Mallareddy, S Singh, L Boghean… - Cancers, 2021 - mdpi.com
moleculemolecular glues are not tied to the dose of these molecular entities but to the
formation of the ternary complex. Here, we provide an overview of PROTACs and molecular glues

[PDF][PDF] Molecular glues are beginning to stick

G Vitale - Chem. Eng. News, 2022 - degrontx.com.cn
molecular glue refers to a small molecule that sticks two proteins together. The most common
type links a target protein-typically one that causes disease-… In the body, the glue molecule